BNTX
Price
$109.00
Change
+$2.93 (+2.76%)
Updated
Jan 16 closing price
Capitalization
27.35B
51 days until earnings call
Intraday BUY SELL Signals
IMTX
Price
$9.83
Change
-$0.09 (-0.91%)
Updated
Jan 16 closing price
Capitalization
1.32B
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BNTX vs IMTX

Header iconBNTX vs IMTX Comparison
Open Charts BNTX vs IMTXBanner chart's image
BioNTech SE American Depositary Share
Price$109.00
Change+$2.93 (+2.76%)
Volume$1.19M
Capitalization27.35B
Immatics
Price$9.83
Change-$0.09 (-0.91%)
Volume$454.23K
Capitalization1.32B
BNTX vs IMTX Comparison Chart in %
View a ticker or compare two or three
VS
BNTX vs. IMTX commentary
Jan 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTX is a Hold and IMTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 18, 2026
Stock price -- (BNTX: $109.00 vs. IMTX: $9.83)
Brand notoriety: BNTX and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNTX: 94% vs. IMTX: 83%
Market capitalization -- BNTX: $27.35B vs. IMTX: $1.32B
BNTX [@Biotechnology] is valued at $27.35B. IMTX’s [@Biotechnology] market capitalization is $1.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNTX’s FA Score shows that 1 FA rating(s) are green whileIMTX’s FA Score has 0 green FA rating(s).

  • BNTX’s FA Score: 1 green, 4 red.
  • IMTX’s FA Score: 0 green, 5 red.
According to our system of comparison, BNTX is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNTX’s TA Score shows that 5 TA indicator(s) are bullish while IMTX’s TA Score has 3 bullish TA indicator(s).

  • BNTX’s TA Score: 5 bullish, 4 bearish.
  • IMTX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BNTX is a better buy in the short-term than IMTX.

Price Growth

BNTX (@Biotechnology) experienced а +9.16% price change this week, while IMTX (@Biotechnology) price change was +7.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

BNTX is expected to report earnings on Mar 10, 2026.

IMTX is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNTX($27.4B) has a higher market cap than IMTX($1.32B). BNTX has higher P/E ratio than IMTX: BNTX (161.76) vs IMTX (27.61). BNTX YTD gains are higher at: 14.496 vs. IMTX (-6.381). BNTX has higher annual earnings (EBITDA): 171M vs. IMTX (-106.34M). BNTX has more cash in the bank: 14.5B vs. IMTX (431M). IMTX has less debt than BNTX: IMTX (16.4M) vs BNTX (245M). BNTX has higher revenues than IMTX: BNTX (3.15B) vs IMTX (84.8M).
BNTXIMTXBNTX / IMTX
Capitalization27.4B1.32B2,079%
EBITDA171M-106.34M-161%
Gain YTD14.496-6.381-227%
P/E Ratio161.7627.61586%
Revenue3.15B84.8M3,717%
Total Cash14.5B431M3,364%
Total Debt245M16.4M1,494%
FUNDAMENTALS RATINGS
BNTX vs IMTX: Fundamental Ratings
BNTX
IMTX
OUTLOOK RATING
1..100
4365
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
9196
PRICE GROWTH RATING
1..100
4941
P/E GROWTH RATING
1..100
165
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMTX's Valuation (75) in the null industry is in the same range as BNTX (86). This means that IMTX’s stock grew similarly to BNTX’s over the last 12 months.

BNTX's Profit vs Risk Rating (97) in the null industry is in the same range as IMTX (100). This means that BNTX’s stock grew similarly to IMTX’s over the last 12 months.

BNTX's SMR Rating (91) in the null industry is in the same range as IMTX (96). This means that BNTX’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's Price Growth Rating (41) in the null industry is in the same range as BNTX (49). This means that IMTX’s stock grew similarly to BNTX’s over the last 12 months.

BNTX's P/E Growth Rating (1) in the null industry is somewhat better than the same rating for IMTX (65). This means that BNTX’s stock grew somewhat faster than IMTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BNTXIMTX
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
BNTX
Daily Signal:
Gain/Loss:
IMTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FKEMX52.730.03
+0.06%
Fidelity Emerging Markets K
GWGIX20.81-0.04
-0.19%
AMG GW&K Small Mid Cap Core I
MNDBX17.75-0.05
-0.28%
MFS New Discovery B
MPAIX27.91-0.12
-0.43%
Morgan Stanley Inst Advantage I
HCPSX90.42-1.09
-1.19%
ProFunds UltraSector Health Care Svc

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with SMMT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
+2.76%
SMMT - BNTX
53%
Loosely correlated
-1.33%
MRNA - BNTX
52%
Loosely correlated
+6.28%
KYMR - BNTX
44%
Loosely correlated
-2.22%
AXON - BNTX
43%
Loosely correlated
-0.18%
IMTX - BNTX
43%
Loosely correlated
-0.91%
More

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IDYA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
-0.91%
IDYA - IMTX
54%
Loosely correlated
-0.61%
VIR - IMTX
49%
Loosely correlated
-2.26%
SYRE - IMTX
48%
Loosely correlated
+0.45%
VYGR - IMTX
48%
Loosely correlated
-1.57%
CGON - IMTX
48%
Loosely correlated
+3.13%
More